Women in EB

  • Claudia Vickers

    Claudia is Director of CSIRO’s Synthetic Biology Future Science Platform (SynBioFSP), a highly collaborative R&D program aimed at expanding Australia’s synthetic biology capability and developing national synthetic biology-based industry. The SynBioFSP works across disciplinary boundaries, exploring both synthetic biology innovation and the social, legal, ethical and institutional issues surrounding bringing this innovation to impact. Her personal research focuses on sustainable alternatives to petrochemicals and other industrial/agricultural products using bio-based solutions. She applies synthetic biology to engineer living cells, re-programming them for production of useful biochemicals or to act as sense/response systems for environmental monitoring and remediation. Her current work is primarily in microbes, but she has a background in plant molecular biology, abiotic stress, and applied plant engineering. She played a leading role in establishing synthetic biology as a field in Australia; she was founding President of Synthetic Biology Australia and co-authored Australia’s national synthetic biology roadmap (delivered by the Australian Council of Learned Academies). She is on the Executive of the International Society for Isoprenoids (TERPNET) and serves on editorial boards for eight international journals. She represents Australia at international strategy and policy fora (US, Asia-Pacific, OECD, World Economic Forum) and sits on the Scientific Advisory Boards for several international synthetic biology institutes and for Food Standards Australia New Zealand (FSANZ). She co-chairs the World Economic Forum Synthetic Biology Future Council. She is experienced in working across disciplinary boundaries and with industry partners.

    Professor Vickers holds a PhD from The University of Queensland and is an Adjunct Professor at Queensland University of Technology and Griffith University.

  • Kate Galloway

    Kate E Galloway is an assistant professor at MIT in the department of Chemical Engineering. Katie Galloway earned her BS in Chemical Engineering from UC Berkeley, PhD in Chemical Engineering at Caltech, and did her postdoc at USC Stem Cell before starting at MIT in the summer of 2019. As a chemical engineer working in molecular systems biology, her research focuses on elucidating the fundamental principles of integrating synthetic circuitry to drive cellular behaviors. Her lab focuses on developing integrated gene circuits and elucidating the systems-level principles that govern complex cellular behaviors. Her team leverages synthetic biology to transform how we understand cellular transitions and engineer cellular therapies. Her research has been featured in Science, Cell Stem Cell, Cell Systems, and Development. She has won multiple fellowships and awards including the NIH F32 and Caltech’s Everhart Award.

  • Renee Wegrzyn

    Renee is a Vice President of Business Development at Ginkgo Bioworks. Prior to Ginkgo, she was Program Manager in the Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA), where she leveraged the tools of synthetic biology and gene editing to enhance biosecurity, support the domestic bioeconomy, and outpace infectious disease. Her DARPA portfolio included the Living Foundries: 1000 Molecules, Safe Genes, Preemptive Expression of Protective Alleles and Response Elements (PREPARE), and Detect it with Gene Editing (DIGET) programs. Prior to joining DARPA as a PM, Renee led teams in private industry in the areas of biosecurity, gene therapies, emerging infectious disease, neuromodulation, synthetic biology, and diagnostics. Renee holds a PhD and BS in Applied Biology from the Georgia Institute of Technology, was a Fellow in the Center for Health Security Emerging Leaders in Biosecurity Initiative (ELBI), and completed her postdoctoral training as an Alexander von Humboldt Fellow in Heidelberg, Germany.

  • Heba Sailem

    Dr Heba Sailem is a Research Fellow at the Institute of Biomedical Engineering and the Big Data Institute. Her expertise transcends computer vision, image informatics, and system genetics which allows her to bring a unique perspective to tackling important challenges in cancer biology. She has pioneered the use of computational methods for knowledge discovery from large scale imaging data. Her work includes developing image analysis algorithms, image informatics, data visualisation and integration.

  • R. Alta Charo

    R. Alta Charo (Harvard, BA biology 1979; Columbia, JD law 1982) is a 2019-2020 Berggruen Fellow at CASBS, and the Warren P. Knowles Professor of Law and Bioethics at the University of Wisconsin, writing on medical ethics and biotechnology regulatory policy. In government, she served as a legal analyst for the former congressional Office of Technology Assessment, policy analyst for the US Agency for International Development and senior policy advisor in the FDA’s Office of the Commissioner. She was a member of the National Bioethics Advisory Commission under President Clinton, and the transition team for President Obama. Charo is a member of the National Academy of Medicine, and co-chaired its committee on Guidelines for Embryonic Stem Cell Research and its 2017 committee on Human Genome Editing: Science, Ethics and Governance. At present, she is a member of the World Health Organization’s committee on global governance of genome editing, of the Nuclear Threat Initiative’s Biosecurity Innovation and Risk Reduction project, and of the steering committee of the International Society for Stem Cell Research’s effort to revise and expand its guidelines for ethical research, including research on chimeras and organoids.

  • Alanna Schepartz

  • Gigi Gronvall

    Gigi Gronvall is a Senior Scholar at the Johns Hopkins Center for Health Security and an Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. Dr. Gronvall is the author of the book Synthetic Biology: Safety, Security, and Promise, published in fall 2016 (Health Security Press) and Preparing for Bioterrorism: The Alfred P. Sloan Foundation’s Leadership in Biosecurity. (2013) She is a member of the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) which provides recommendations to the NIH Director and is a public forum for the discussion of the scientific, safety, and ethical issues associated with emerging biotechnologies. Dr. Gronvall is a member of the Threat Reduction Advisory Committee (TRAC), which provides the Secretary of Defense with independent advice and recommendations on reducing the risk to the United States, its military forces, and its allies and partners posed by nuclear, biological, chemical, and conventional threats. She served as the Science Advisor for the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism from April 2009 until February 2010. Dr. Gronvall is an Associate Editor of the journal Health Security, and is a Life Member of the Council on Foreign Relations. She was a National Research Council Postdoctoral Associate at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, Maryland. Dr. Gronvall received a BS in biology from Indiana University, Bloomington, worked as a protein chemist at the Memorial Sloan-Kettering Cancer Center and received a PhD from Johns Hopkins University for work on T-cell receptor/MHC I interactions.

  • Deepti Tanjore

    At ABPDU, our passion for bio-innovation drives us. Every day. Whether we’re evaluating biomass, experimenting with microorganisms, optimizing new processes, or performing assays and analyses, our end goal never changes. Simply put, we want to enable you to successfully take your bio-innovation to market.

    We’ve been operational since 2012, collaborating with researchers in the bio-products industry, the National Labs, and academia to optimize and scale technologies to enable the commercialization of bio-based chemicals, materials, and fuels.

  • Laura Segatori

    Laura Segatori is an Associate Professor in Bioengineering at Rice University. She received a Laurea in Industrial Biotechnology from the University of Bologna in Italy in 2000 and a PhD in Chemical Engineering from the University of Texas at Austin in 2005. She completed her postdoctoral work at The Scripps Research Institute in La Jolla, CA and joined the faculty at Rice University in 2007 where she holds joint appointments in the departments of Chemical & Biomolecular Engineering and Biosciences. Her research group is highly interdisciplinary and combines principles and tools from engineering and science to decipher and manipulate cellular quality control mechanisms that underlie the development of human diseases. Current research interests are centered on reprogramming mammalian cells for the development of cell-based therapies and biomanufacturing.

  • Domitilla Del Vecchio

    Domitilla Del Vecchio received the Ph. D. degree in Control and Dynamical Systems from the California Institute of Technology, Pasadena, and the Laurea degree in Electrical Engineering (Automation) from the University of Rome at Tor Vergata in 2005 and 1999, respectively. From 2006 to 2010, she was an Assistant Professor in the Department of Electrical Engineering and Computer Science and in the Center for Computational Medicine and Bioinformatics at the University of Michigan, Ann Arbor. In 2010, she joined Department of Mechanical Engineering at the Massachusetts Institute of Technology (MIT), where she is currently Professor and member of the Synthetic Biology Center. She is a recipient of the 2016 Bose Research Award (MIT), the Donald P. Eckman Award from the American Automatic Control Council (2010), the NSF Career Award (2007), the American Control Conference Best Student Paper Award (2004), and the Bank of Italy Fellowship (2000).

  • Anne Meyer

    The Meyer lab performs research targeted at re-engineering bacteria to synthesize bio-inspired materials with improved properties. This approach has the potential to replace traditional chemical approaches that require extreme environmental conditions, expensive equipment, and the generation of hazardous waste. As a first step we have targeted bacterial production of patterned artificial nacre, a biomineralized material lining seashells that combines high mechanical strength with high fracture toughness. Combination of our biological materials-producing systems with our newly developed 3D bacterial printers will allow the rapid and straight-forward production of spatially structured biomaterials.

  • Mary Dunlop

    Mary Dunlop is an Associate Professor of Biomedical Engineering at Boston University with additional appointments in Molecular Biology, Cell Biology & Biochemistry and Bioinformatics. She graduated from Princeton University with a B.S.E. in Mechanical and Aerospace Engineering and a minor in Computer Science. She then received her Ph.D. from the California Institute of Technology, where she studied synthetic biology with a focus on dynamics and feedback in gene regulation. As a postdoctoral scholar, she conducted research on biofuel production at the Department of Energy’s Joint BioEnergy Institute. Her lab engineers novel synthetic feedback control systems and also studies naturally occurring examples of feedback in gene regulation. In recognition of her outstanding research and service contributions, she has received many honors including a Department of Energy Early Career Award, a National Science Foundation CAREER Award, and the ACS Synthetic Biology Young Investigator Award.

  • Yvonne Chen

    Yvonne Chen

    Dr. Yvonne Chen is an Associate Professor of Microbiology, Immunology, and Molecular Genetics at the University of California, Los Angeles. She is also a faculty, by courtesy, in the Department of Chemical and Biomolecular Engineering. The Chen Laboratory focuses on applying synthetic biology and biomolecular engineering techniques to the development of novel mammalian-cell systems. The Chen Lab’s work on engineering next-generation T-cell therapies for cancer has been recognized by the NIH Director’s Early Independence Award, the NSF CAREER Award, the Hellman Fellowship, the ACGT Young Investigator Award in Cell and Gene Therapy for Cancer, the Mark Foundation Emerging Leader Award, and the Cancer Research Institute Lloyd J. Old STAR Award. Prior to joining UCLA in 2013, Yvonne was a Junior Fellow in the Harvard Society of Fellows. She received postdoctoral training at the Center for Childhood Cancer Research within the Seattle Children’s Research Institute, and in the Department of Systems Biology at Harvard Medical School. Yvonne received her B.S. in Chemical Engineering from Stanford University and her Ph.D. in Chemical Engineering from the California Institute of Technology.

  • Natalie Kuldell

    Dr. Natalie Kuldell leads BioBuilder, a nonprofit organization that inspires the next generation of innovators with authentic science and engineering. BioBuilder’s synthetic biology curriculum breeds excitement by helping students and teachers design and then build
    biotechnologies that solve real problems throughout the US and around the world. A BioBuilder textbook was published by O’Reilly Media. In 2017, BioBuilder opened a community lab in Kendall Square’s LabCentral.

    Dr. Kuldell studied Chemistry as an undergraduate at Cornell, completed her doctoral and post-doctoral work at Harvard Medical School, and taught at Wellesley College before joining the Department of Biological Engineering faculty at MIT in 2003. She is the 2020 recipient of the Margret and H.A. Rey Curiosity Award.

  • Elisa Franco

    Elisa Franco

  • Kathleen Vogel

    policy, biosecurity, defense applications

  • Melissa Rhoads

    biological sciences, cell and molecular biology, project management, systems engineering, technical writing, team building

  • Arti Rai

    intellectual property, policy, biotechnology, pharmaceuticals

  • Jackie Quinn

    bioengineering, design languages, computer aided design, computational tools

    • Back to top ⇑